Thus, the debate about the major source of RANKL in the tumor microenvironment—osteocytes vs. cancer cells or other cells of the bone marrow (i.e., immune cells, adipocytes, osteoblasts, progenitors)—remains unresolved. The gene discussed is TNFSF11; the disease is cancer.